Exact Mass: 308.165531
Exact Mass Matches: 308.165531
Found 500 metabolites which its exact mass value is equals to given mass value 308.165531,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Phenylbutazone
A drug that has anti-inflammatory, antipyretic, and analgesic activities. It is especially effective in the treatment of ankylosing spondylitis. It also is useful in rheumatoid arthritis and Reiter's syndrome (investigational indication). Although phenylbutazone is effective in gouty arthritis, risk/benefit considerations indicate that this drug should not be employed for this disease. (From AMA Drug Evaluations Annual, 1994, p1822) M - Musculo-skeletal system > M02 - Topical products for joint and muscular pain > M02A - Topical products for joint and muscular pain > M02AA - Antiinflammatory preparations, non-steroids for topical use M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AA - Butylpyrazolidines C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics CONFIDENCE standard compound; EAWAG_UCHEM_ID 3615 EAWAG_UCHEM_ID 3615; CONFIDENCE standard compound CONFIDENCE standard compound; INTERNAL_ID 1158 D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents
bestatin
KEIO_ID B018; [MS2] KO009090 KEIO_ID B018 Bestatin is a natural, broad-spectrum, and competitive CD13 (Aminopeptidase N)/APN and leukotriene A4 hydrolase inhibitor. Bestatin has anticancer effects[1][2].
Inulicin
Britannilactone 1-O-acetate is a natural product found in Pentanema britannicum and Inula japonica with data available. Inulicin (1-O-Acetylbritannilactone) is an active compound that inhibits VEGF-mediated activation of Src and FAK. Inulicin (1-O-Acetylbritannilactone) inhibits LPS-induced PGE2 production and COX-2 expression, and NF-κB activation and translocation. Inulicin (1-O-Acetylbritannilactone) is an active compound that inhibits VEGF-mediated activation of Src and FAK. Inulicin (1-O-Acetylbritannilactone) inhibits LPS-induced PGE2 production and COX-2 expression, and NF-κB activation and translocation.
DMXB-A
D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018679 - Cholinergic Agonists
2-(3,7-Dimethyl-2,6-octadienyl)-3-methyl-1,4-naphthoquinone
2-[(2E)-3,7-dimethylocta-2,6-dienyl]-5-methylnaphthalene-1,4-dione
15-Deacetylcalonectrin
15-Deacetylcalonectrin is a metabolite of Calonectria nivali
ACRL Toxin II
ACRL Toxin II is found in citrus. ACRL Toxin II is produced by the fungus Alternaria citri on rough lemo Production by the fungus Alternaria citri on rough lemon. ACRL Toxin II is found in citrus.
Dihydrocumambrin A
Dihydrocumambrin A is found in garland chrysanthemum. Dihydrocumambrin A is from Chrysanthemum coronarium (chop-suey greens). From Chrysanthemum coronarium (chop-suey greens). Dihydrocumambrin A is found in garland chrysanthemum and herbs and spices.
Gestrinone
Gestrinone was developed in the early 1970s and was tested clinically as a weekly oral contraceptive in European and North American countries. ]. Without significant advantages over other oral contraceptives and with its high price, gestrinone was no longer used after the Stage II clinical trial. However, from 1982 aroused widespread interest due to substantial therapeutic effects in treating endometriosis. Under different endocrine conditions, gestrinone possesses estrogenic, progestational, androgenic, antiestrogenic and antiprogesterone actions. Starting from gestrinone, chemists can synthesize tetrahydrogestrinone (THG) in one reaction step. THG is a real designer steroid; designer steroids (chemically modified steroids) pose a threat to the integrity of the sport community. These compounds have recently been detected in urine specimens from athletes, resulting in temporary or permanent suspension from amateur and/or professional competition. (PMID: 15934041, 17707720) [HMDB] Gestrinone was developed in the early 1970s and was tested clinically as a weekly oral contraceptive in European and North American countries. ]. Without significant advantages over other oral contraceptives and with its high price, gestrinone was no longer used after the Stage II clinical trial. However, from 1982 aroused widespread interest due to substantial therapeutic effects in treating endometriosis. Under different endocrine conditions, gestrinone possesses estrogenic, progestational, androgenic, antiestrogenic and antiprogesterone actions. Starting from gestrinone, chemists can synthesize tetrahydrogestrinone (THG) in one reaction step. THG is a real designer steroid; designer steroids (chemically modified steroids) pose a threat to the integrity of the sport community. These compounds have recently been detected in urine specimens from athletes, resulting in temporary or permanent suspension from amateur and/or professional competition. (PMID: 15934041, 17707720). G - Genito urinary system and sex hormones > G03 - Sex hormones and modulators of the genital system > G03X - Other sex hormones and modulators of the genital system > G03XA - Antigonadotropins and similar agents D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D011372 - Progestins C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents
Fructosyllysine
1-[(5-Amino-5-carboxypentyl)amino]-1-deoxyfructose is found in milk and milk products. Amadori rearrangement produced found in heated milk and other foodstuff Amadori rearrangement production found in heated milk and other foodstuffs Fructosyl-lysine (Fructoselysine) is an amadori glycation product from the reaction of glucose and lysine by the Maillard reaction. Fructosyl-lysine is the precursor to glucosepane, a lysine–arginine protein cross-link that can be an indicator in diabetes?detection[1].
8-Hydroxycarteolol
8-Hydroxycarteolol is a metabolite of carteolol. Carteolol (trade names Cartrol, Ocupress, Teoptic, Arteolol, Arteoptic, Calte, Cartéabak, Carteol, Cartéol, Cartrol, Elebloc, Endak, Glauteolol, Mikelan, Poenglaucol, Singlauc) is a non-selective beta blocker used to treat glaucoma. (Wikipedia)
1-Deoxy-1-(N6-lysino)-D-fructose
1-Deoxy-1-(N6-lysino)-D-fructose is a very strong basic compound (based on its pKa).
(2R)-2-Amino-6-[[(3S,4R,5R)-3,4,5,6-tetrahydroxy-2-oxohexyl]amino]hexanoic acid
(2R)-2-[[(2S,3R)-3-Amino-2-hydroxy-4-phenyl-butanoyl]amino]-4-methyl-pentanoic acid
1-O-Acetyl britannilactone
Inulicin (1-O-Acetylbritannilactone) is an active compound that inhibits VEGF-mediated activation of Src and FAK. Inulicin (1-O-Acetylbritannilactone) inhibits LPS-induced PGE2 production and COX-2 expression, and NF-κB activation and translocation. Inulicin (1-O-Acetylbritannilactone) is an active compound that inhibits VEGF-mediated activation of Src and FAK. Inulicin (1-O-Acetylbritannilactone) inhibits LPS-induced PGE2 production and COX-2 expression, and NF-κB activation and translocation.
4-Butyl-5-hydroxy-1,2-diphenylpyrazol-3-one
Baquiloprim
C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent
3-(2,4-Dimethoxybenzylidene)anabaseine
n-octyl-beta-D-thioglucopyranoside
C14H28O5S (308.16573580000005)
Ubenimex
Ubenimex (also known as bestatin) is a competitive protease inhibitor. It is an inhibitor of aminopeptidase B, leukotriene A4 hydrolase, aminopeptidase N. It is being studied for use in the treatment of acute myelocytic leukemia. Ubenimex is a microbial metabolite and dipeptide with potential immunomodulatory and antitumor activities. Ubenimex competitively inhibits many aminopeptidases, including B, N and leucine aminopeptidases. Aminopeptidases has been implicated in the process of cell adhesion and invasion of tumor cells. Therefore, inhibiting aminopeptidases may partially attribute to the antitumor effect of ubenimex. This agent also activates T lymphocyte, macrophage and bone marrow stem cell as well as stimulates release of interleukin-1 and -2, thus further enhances its antitumor activity. D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors C308 - Immunotherapeutic Agent > C2139 - Immunostimulant D000970 - Antineoplastic Agents D007155 - Immunologic Factors Bestatin is a natural, broad-spectrum, and competitive CD13 (Aminopeptidase N)/APN and leukotriene A4 hydrolase inhibitor. Bestatin has anticancer effects[1][2].
Dihydro-beta-cyclopyrethrosin
4beta-Acetoxy-6alpha-hydroxy-11(13)-pseudoguaien-12,8alpha-olide
Torrentin
Nematolin
nitrosin
6alpha-Acetoxy-4beta-hydroxy-11(13)-pseudoguaien-12,8alpha-olide
Diacetolol
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist
Baquiloprim
C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent CONFIDENCE standard compound; INTERNAL_ID 1178
1-Acetylerivanin|1alpha-acetoxy-3alpha-hydroxy-5,7alpha,6,11beta(H)-eudesm-4,15-en-6,12-olide
1alpha-acetoxy-4alpha-hydroxy-5,7alpha,6,11beta(H)-eudesm-2,3-en-6,12-olide|1alpha-Acetoxy-4alpha-hydroxy-5alpha,6beta,7alpha,11beta-H-eudesm-2-en-12,6-olide
8-Ac-(1beta,6alpha,8beta,11alphaH)-1,8-Dihydroxy-3-eudesmen-12,6-olide
1-(2,2-dimethyl-3-hydroxypropyl)-2-isobutyl phthalate
1alpha-acetoxy-5beta-hydroxyeudesm-3-en-6beta,11betaH-12,6-olide
3,4,5-Tri-Me ether,O-(3-methylbutanoyl)-3-(3,4,5-Trihydroxyphenyl)-2-propen-1-ol|3,4,5-trimethoxycinnamyl isovalerate
8beta-Acetoxy-3beta-hydroxy-11alpha,13-dihydrocostunolid
8-Hydroxy-3,8a-dimethyl-5-methylene-2-oxododecahydronaphtho[2,3-b]furan-4-yl acetate #
(4S,4aR,5S,8aR,9aS)-4-(acetyloxy)-4a,5,6,7,8,8a,9,9a-octahydro-9a-hydroxy-3,4a,5-trimethylnaphtho[2,3-b]furan-2(4H)-one|(6beta,8alpha)-6-(acetyloxy)-8-hydroxyeremophil-7(11)-en-12,8-olide
4-Ac-4,5-Seconeopulchell-5-ene|4-O-acetyl-4,5-seco-neopulchell-5-ene
4-acetoxy-1beta,5beta-epoxy-10alphaH-xantha-11(13)-en-12,8beta-olide|4-Acetoxy-1??,5??-epoxy-10??H-xantha-11(13)-en-12,8??-olide
1beta,6alpha,8beta-Trihydroxy-11,13-dihydroeudesm-4-en-6-olide 8-acetate
9beta-acetoxy-15-hydroxyeudesm-4,11(13)-dien-12-oic acid
2,2-Dimethyl-5,6,8-trimethoxy-7-(1-methoxyethyl)-2H-1-benzopyran
3alpha-acetoxy-11alphaH,13-dihydrodamsin|hydroxydihydrodamsin
Ac-(1alpha,3beta,4Z,8beta,10beta,11alpha)-1,10-Epoxy-3-hydroxy-4-germacren-12,8-olide
2alpha-acetoxy-5alpha-hydroxy-11alphaH-eudesma-4(15)-en-12,8beta-olide
4beta,5beta-epoxy-9beta-acetoxyeudesm-11(13)-en-12-oic acid
(1R*,4R*,5R*)-5-hydroxy-4-[(E)-7-hydroxy-4-methylhept-3-enyl]-4,8-dimethyl-3-oxabicyclo[3.3.0]octan-7-en-2,6-dione|gomadalactone B
(3R),(4S)-4-hydroxylasiodiplodin|(3R,4S)-4-hydoxylasiodiplodin
1beta-acetoxy-7-drimen-11alpha-ol-12,11-lactone|1??-Acetoxy-7-drimen-11??-ol-12,11-lactone
(1S,4S,5S,6S,7S,10R)-1-hydroxy-15-acetoxyeudesm-11(13)-en-6,12-olide
1alpha-acetoxy-3beta-hydroxyeudesm-4-en-6beta,11betaH-12,6-olide
6alpha-acetoxy-1-hydroxy-4alphaH-1,10-secoeudesma-5(10),11(13)-dien-12,8beta-olide
11alpha,13-dihydro-2-O-acetylflorilenalin|11alphaH,13dihydroflorilenalin acetate|2alpha-acetoxy-4alpha-hydroxy-1beta,5alpha,11alphaH-guai-10(14)-en-12,8beta-olide
2-Ac-4,5-Seconeopulchell-5-ene|4,5-seco-neopulchell-5-ene-2-O-acetate
(1S,2R,5R,6S,7S,8S,10R)-6-hydroxy-2-ethoxy-4-oxopseudoguai-11(13)-en-12,8-olide
A pseudoguaianolide with anti-inflammatory activity isolated from the aerial parts of Inula hupehensis.
15-hydroxyajanolide A|3beta-acetoxy-15-hydroxygermacra-1(10)E,4Z-dien-6beta,7alpha,11alphaH-12,6-olide|zawadskinolide B
3beta-acetoxy-5alpha-angeloyloxy-7-deoxycarvotacetone|vernonione
2beta-acetoxy-4alpha-hydroxy-11beta,13-dihydroburkeolide
9-Ac-(5alpha,9??)-5,9-Dihydroxy-4(15),11(13)-eudesmadien-12-oic acid|9beta-Acetoxy-5alpha-hydroxycostic Acid
7,8-seco-2,3,5-trihydroxy-12-acetoxycalam-8-ene|myrracalamene B
10betaH,11alphaH-7alpha-acetoxy-8-oxoeremophilan-12,6beta-olide|7-O-acetylsubspicatolide
11-hydroxy-1beta-methoxy-8-oxoeremophila-6,9-dien-12-oic acid methyl ester
4-Ac-4, 10-Dihydroxy-11(13)-guaien-12, 8-olide|4alpha-acetoxy-10beta-hydroxy-1beta(H),5alpha(H)-guai-11(13)-en-8alpha,12-olide
(+)-(4aS,12bS)-4,4,12b-trimethyl-1,2,3,4,4a,5,6,12b-octahydrobenzo[a]anthracene-8,11-dione|(+)-cyclozonarone|Cyclozonarone
1alpha-hydroxy-4beta-O-acetylpseudoguaian-6beta,12-olide
2,4-Dihydroxy-3,6-dimethoxy-5-(3,3-dimethylallyl)-butyrophenon
1H-(Indol-3-yl)-6,7-dimethoxy-1,2,3,4-tetrahydro-isoquinoline
Vincanidine
Origin: Plant; Formula(Parent): C19H20N2O2; Bottle Name:Vincanidine; PRIME Parent Name:Vincanidine; PRIME in-house No.:V0312; SubCategory_DNP: Monoterpenoid indole alkaloids, Aspidosperma alkaloids, Indole alkaloids Annotation level-1
(11S,17S)-12-ethylidene-6-hydroxy-8,14-diazapentacyclo(9.5.2.0(1,9).0(2,7).0(14,17))octadeca-2(7),3,5,9-tetraene-10-carbaldehyde
Origin: Plant; Formula(Parent): C19H20N2O2; Bottle Name:Vincanidine; PRIME Parent Name:Vincanidine; PRIME in-house No.:V0312; SubCategory_DNP: Monoterpenoid indole alkaloids, Aspidosperma alkaloids, Indole alkaloids Formula(Parent): C19H20N2O2; Bottle Name:Vincanidine; Origin: Plant; PRIME Parent Name:Vincanidine; PRIME in-house No.:V0312; SubCategory_DNP: Monoterpenoid indole alkaloids, Aspidosperma alkaloids, Indole alkaloids PRIME in-house No.:V0312; Origin: Plant; Formula(Parent): C19H20N2O2; Bottle Name:Vincanidine; PRIME Parent Name:Vincanidine; SubCategory_DNP: Monoterpenoid indole alkaloids, Aspidosperma alkaloids, Indole alkaloids
Fructoselysine
A glyco-amino acid consisting of a D-fructosyl residue attached to the epsilon-amino group of L-lysine.
UK-156819
CONFIDENCE standard compound; INTERNAL_ID 836; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4744; ORIGINAL_PRECURSOR_SCAN_NO 4743 CONFIDENCE standard compound; INTERNAL_ID 836; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3450; ORIGINAL_PRECURSOR_SCAN_NO 3448 CONFIDENCE standard compound; INTERNAL_ID 836; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3446; ORIGINAL_PRECURSOR_SCAN_NO 3443 CONFIDENCE standard compound; INTERNAL_ID 836; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3439; ORIGINAL_PRECURSOR_SCAN_NO 3437 CONFIDENCE standard compound; INTERNAL_ID 836; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3452; ORIGINAL_PRECURSOR_SCAN_NO 3448 CONFIDENCE standard compound; INTERNAL_ID 836; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4773; ORIGINAL_PRECURSOR_SCAN_NO 4772 CONFIDENCE standard compound; INTERNAL_ID 836; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7655; ORIGINAL_PRECURSOR_SCAN_NO 7653 CONFIDENCE standard compound; INTERNAL_ID 836; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7663; ORIGINAL_PRECURSOR_SCAN_NO 7661 CONFIDENCE standard compound; INTERNAL_ID 836; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7644; ORIGINAL_PRECURSOR_SCAN_NO 7642 CONFIDENCE standard compound; INTERNAL_ID 836; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7660; ORIGINAL_PRECURSOR_SCAN_NO 7658 CONFIDENCE standard compound; INTERNAL_ID 836; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7675; ORIGINAL_PRECURSOR_SCAN_NO 7673 CONFIDENCE standard compound; INTERNAL_ID 836; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7714; ORIGINAL_PRECURSOR_SCAN_NO 7712
8-(3-Methoxy-2-(methoxycarbonyl)phenyl)octanoic acid
Gestrinone
G - Genito urinary system and sex hormones > G03 - Sex hormones and modulators of the genital system > G03X - Other sex hormones and modulators of the genital system > G03XA - Antigonadotropins and similar agents D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D011372 - Progestins C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents
Fructosyllysine
Fructosyl-lysine (Fructoselysine) is an amadori glycation product from the reaction of glucose and lysine by the Maillard reaction. Fructosyl-lysine is the precursor to glucosepane, a lysine–arginine protein cross-link that can be an indicator in diabetes?detection[1].
15-Decalonectrin
Dihydrocumambrin A
15-Acetoxyscirpenol
Mycotoxin from Fusarium roseum and Fusarium sulphureum
4-(PHENYLCARBONYL)PHENYLBORONIC ACID, PINACOL ESTER
(E)-2-(4-METHOXY-3-(3-METHOXYPROPOXY)BENZYLIDENE)-3-METHYLBUTANOIC ACID
4-Boc-7,8-Dimethoxy-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepine
1H-Pyrrolo[2,3-b]pyridin-5-ol, 4-fluoro-1-[tris(1-methylethyl)silyl]-
Octyl thioglucoside
C14H28O5S (308.16573580000005)
D013501 - Surface-Active Agents > D003902 - Detergents
2-(9H-CARBAZOLYL)ETHYLBORONIC ACID DIETHANOLAMINE ESTER
3-(2-MALEIMIDOETHYLCARBAMOYL)-2,2,5,5-TETRAMETHYL-1-PYRROLIDINYLOXY
methyl 3,3-dimethoxy-2-oxa-7,10-diaza-3-silatridecan-13-oate
tert-butyl N-[1-(benzylamino)-3-methoxy-1-oxopropan-2-yl]carbamate
(S)-ETHYL 3-(4-AMINOPHENYL)-2-((TERT-BUTOXYCARBONYL)AMINO)PROPANOATE
tert-Butyl 4-(2-fluoro-6-formylphenyl)piperazine-1-carboxylate
Benzeneacetic acid,2-[2-(dipropylamino)ethyl]-6-nitro-
(R)-tert-Butyl 1-(benzylamino)-3-methoxy-1-oxopropan-2-ylcarbamate
3-Fluoro-2-(4-morpholino)pyridine-4-boronic acid pinacol ester
TERT-BUTYL 2-(1-(4-(ETHOXYCARBONYL)PHENYL)ETHYL)HYDRAZINECARBOXYLATE
(4-((2-((tert-Butoxycarbonyl)amino)ethyl)carbamoyl)phenyl)boronic acid
Derenofylline
C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator Derenofylline (SLV 320) is a potent, selective and orally active adenosine A1 receptor antagonist, with Ki values of 1 nM, 200 nM and 398 nM for human A1, A3 and A2A receptors respectively. Derenofylline suppresses cardiac fibrosis and attenuates albuminuria without affecting blood pressure in rats[1].
Dimethisoquin hydrochloride
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent
2-Amino-6-[(3,4,5,6-tetrahydroxy-2-oxohexyl)amino]hexanoic acid (non-preferred name)
N-[2-(5-methoxy-2-phenyl-1H-indol-3-yl)ethyl]acetamide
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
3-[(2,5-dimethylanilino)methyl]-6-methoxy-1H-quinolin-2-one
33627-41-7
Inulicin (1-O-Acetylbritannilactone) is an active compound that inhibits VEGF-mediated activation of Src and FAK. Inulicin (1-O-Acetylbritannilactone) inhibits LPS-induced PGE2 production and COX-2 expression, and NF-κB activation and translocation. Inulicin (1-O-Acetylbritannilactone) is an active compound that inhibits VEGF-mediated activation of Src and FAK. Inulicin (1-O-Acetylbritannilactone) inhibits LPS-induced PGE2 production and COX-2 expression, and NF-κB activation and translocation.
Furan-2-ylmethyl-(2-piperidin-1-yl-quinazolin-4-yl)-amine
12-Ethylidene-6-hydroxy-8,14-diazapentacyclo[9.5.2.01,9.02,7.014,17]octadeca-2(7),3,5,9-tetraene-10-carbaldehyde
(1R,11S,12E,17S)-12-ethylidene-6-hydroxy-8,14-diazapentacyclo[9.5.2.01,9.02,7.014,17]octadeca-2(7),3,5,9-tetraene-10-carbaldehyde
fructosyl-lysine
Fructosyl-lysine (Fructoselysine) is an amadori glycation product from the reaction of glucose and lysine by the Maillard reaction. Fructosyl-lysine is the precursor to glucosepane, a lysine–arginine protein cross-link that can be an indicator in diabetes?detection[1].
[(1R,2R,10R)-2-(hydroxymethyl)-1,5-dimethylspiro[8-oxatricyclo[7.2.1.02,7]dodec-5-ene-12,2-oxirane]-10-yl] acetate
2-[(3-Azaniumyl-2-hydroxy-4-phenylbutanoyl)amino]-4-methylpentanoate
2-[2-(3-Ethylphenoxy)ethyl]propanedioic acid diethyl ester
1-[(3-chlorophenyl)methyl]-N,N-diethyl-3-piperidinecarboxamide
1-O-acetyl-4R,6S-britannilactone
A sesquiterpene lactone that is (3aS,4R,7aR)-3a,4,7,7a-tetrahydro-1-benzofuran-2(3H)-one with a methylidene at position C-3, a hydroxy at C-4, a methyl at C-6, and a (2S)-5-(acetyloxy)pentan-2-yl group at position C-5. A natural product found in Inula britannica var chinensis and Inula japonica.
N-[(2R,3R,6S)-6-[2-(cyclobutylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]cyclopropanecarboxamide
N-[(2R,3S,6S)-6-[2-(cyclobutylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]cyclopropanecarboxamide
N-[(2S,3S,6S)-6-[2-(cyclobutylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]cyclopropanecarboxamide
N-[(2S,3R,6R)-6-[2-(cyclobutylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]cyclopropanecarboxamide
N-[(2S,3R,6S)-6-[2-(cyclobutylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]cyclopropanecarboxamide
N-[(2R,3R,6R)-6-[2-(cyclobutylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]cyclopropanecarboxamide
N-[(2R,3S,6R)-6-[2-(cyclobutylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]cyclopropanecarboxamide
N-[(2S,3S,6R)-6-[2-(cyclobutylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]cyclopropanecarboxamide
(8S,13S,14R,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
1-(1H-indol-3-yl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline
(1R,11R,12E,17S)-12-ethylidene-6-hydroxy-8,14-diazapentacyclo[9.5.2.01,9.02,7.014,17]octadeca-2(7),3,5,9-tetraene-10-carbaldehyde
13-Ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
(12Z)-12-ethylidene-6-hydroxy-8,14-diazapentacyclo[9.5.2.01,9.02,7.014,17]octadeca-2(7),3,5,9-tetraene-10-carbaldehyde
3-(2,4-Dimethoxybenzylidene)anabaseine
D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018679 - Cholinergic Agonists
(2R)-2-[[(2S,3R)-3-Amino-2-hydroxy-4-phenyl-butanoyl]amino]-4-methyl-pentanoic acid
Bestatin is a natural, broad-spectrum, and competitive CD13 (Aminopeptidase N)/APN and leukotriene A4 hydrolase inhibitor. Bestatin has anticancer effects[1][2].
3-[(3aS,4R,5R,8aR)-4-hydroxy-5,7-dimethyl-3-methylidene-2-oxo-4,5,8,8a-tetrahydro-3aH-cyclohepta[b]furan-6-yl]propyl acetate
Inulicin (1-O-Acetylbritannilactone) is an active compound that inhibits VEGF-mediated activation of Src and FAK. Inulicin (1-O-Acetylbritannilactone) inhibits LPS-induced PGE2 production and COX-2 expression, and NF-κB activation and translocation. Inulicin (1-O-Acetylbritannilactone) is an active compound that inhibits VEGF-mediated activation of Src and FAK. Inulicin (1-O-Acetylbritannilactone) inhibits LPS-induced PGE2 production and COX-2 expression, and NF-κB activation and translocation.
[(2S,3R)-3-Amino-2-hydroxy-4-phenylbutyryl]-L-leucine
1-[(5-Amino-5-carboxypentyl)amino]-1-deoxyfructose
psicosyllysine
An L-lysine derivative having a psicosyl group attached to the side-chain amino group.
(3r,3ar,4s,9r,11ar)-9-hydroxy-3,6,10-trimethyl-2-oxo-3h,3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-4-yl acetate
(2s,4s)-4-[(3ar,7s,8as)-7-methyl-3-methylidene-2-oxo-3ah,4h,7h,8h,8ah-cyclohepta[b]furan-6-yl]-4-hydroxybutan-2-yl acetate
1-[2,4-dihydroxy-3,6-dimethoxy-5-(3-methylbut-2-en-1-yl)phenyl]butan-1-one
(3s)-7,12-dihydroxy-14-methoxy-3-methyl-3,4,5,6,7,8,9,10-octahydro-2-benzoxacyclododecin-1-one
(3s,3ar,5ar,6s,7s,9as,9bs)-6-hydroxy-3,5a-dimethyl-9-methylidene-2-oxo-octahydro-3h-naphtho[1,2-b]furan-7-yl acetate
(3s,5s)-5,12-dihydroxy-14-methoxy-3-methyl-3,4,5,6,7,8,9,10-octahydro-2-benzoxacyclododecin-1-one
(1r,5as,9r,9as,9br)-1-hydroxy-6,6,9a-trimethyl-3-oxo-1h,5h,5ah,7h,8h,9h,9bh-naphtho[1,2-c]furan-9-yl acetate
(4as,12bs)-4,4,12b-trimethyl-1,2,3,4a,5,6-hexahydrotetraphene-8,11-dione
[(3s,3as,6s,6as,9as,9br)-3,6-dimethyl-2,9-dioxo-octahydro-3h-azuleno[4,5-b]furan-9a-yl]methyl acetate
(9s,10s,11ar)-9-hydroxy-3,6,10-trimethyl-2-oxo-4h,5h,8h,9h,11h,11ah-cyclodeca[b]furan-10-yl acetate
{9-hydroxy-6-methyl-3-methylidene-2-oxo-octahydro-3ah-azuleno[4,5-b]furan-9a-yl}methyl acetate
4-hydroxy-3,6,10-trimethyl-2-oxo-3h,3ah,4h,7h,8h,11h,11ah-cyclodeca[b]furan-7-yl acetate
6-[(3r,4e,6s,7s,8e)-3,7-dihydroxy-6,8-dimethyldeca-4,8-dien-2-yl]-4-hydroxypyran-2-one
(3as,6s,6as,9s,9as,9br)-6-(hydroxymethyl)-9a-methyl-3-methylidene-2-oxo-octahydro-3ah-azuleno[4,5-b]furan-9-yl acetate
2-[(1s,2r,5s)-2-(acetyloxy)-5-methyl-4-(3-oxobutyl)cyclohept-3-en-1-yl]prop-2-enoic acid
(3s,7e,8r)-7-ethylidene-5-methyl-5,12-diazatetracyclo[9.7.0.0³,⁸.0¹³,¹⁸]octadeca-1(11),13,15,17-tetraene-2,10-dione
(3s,3ar,4s,6r,6ar,9ar,9bs)-6-hydroxy-3,6,9-trimethyl-2-oxo-3h,3ah,4h,5h,6ah,7h,9ah,9bh-azuleno[4,5-b]furan-4-yl acetate
(3r,5r)-5,12-dihydroxy-14-methoxy-3-methyl-3,4,5,6,7,8,9,10-octahydro-2-benzoxacyclododecin-1-one
(4ar,5s,8r,8as,9ar)-9a-hydroxy-3,4a,5-trimethyl-2-oxo-4h,5h,6h,7h,8h,8ah,9h-naphtho[2,3-b]furan-8-yl acetate
6-[(2r,3s,4e,6s,7r,8e)-3,7-dihydroxy-6,8-dimethyldeca-4,8-dien-2-yl]-4-hydroxypyran-2-one
{2-[2-(tert-butoxy)-5-methoxy-4-methylphenyl]oxiran-2-yl}methyl acetate
4,4,12b-trimethyl-1,2,3,4a,5,6-hexahydrotetraphene-8,11-dione
[2-(hydroxymethyl)-3-methoxy-4-methyl-5-[(3-methylbut-2-en-1-yl)oxy]phenyl]methyl acetate
8-hydroxy-5,5,8-trimethyl-10-oxo-11-oxatetracyclo[7.3.1.0¹,⁹.0³,⁷]tridecan-2-yl acetate
[(3as,6s,6as,9s,9ar,9br)-9-hydroxy-6-methyl-3-methylidene-2-oxo-octahydro-3ah-azuleno[4,5-b]furan-9a-yl]methyl acetate
4-{7-hydroxy-7-methyl-3-methylidene-2-oxo-3ah,4h,8h,8ah-cyclohepta[b]furan-6-yl}butan-2-yl acetate
(3r,3as,4r,7s,11as)-4-hydroxy-3,6,10-trimethyl-2-oxo-3h,3ah,4h,7h,8h,11h,11ah-cyclodeca[b]furan-7-yl acetate
(1r,4r,7r,8s,12s)-1-hydroxy-7-(2-hydroxypropan-2-yl)-4-methyl-3,13-dioxatetracyclo[10.2.1.0²,¹⁰.0⁴,⁸]pentadec-2(10)-en-11-one
(1r,3s)-1-[(3as,7s,8as)-7-methyl-3-methylidene-2-oxo-3ah,4h,7h,8h,8ah-cyclohepta[b]furan-6-yl]-3-hydroxybutyl acetate
(1s)-1-[(3s,3ar,7s,8ar)-3,7-dimethyl-2-oxo-3h,3ah,4h,7h,8h,8ah-cyclohepta[b]furan-6-yl]-3-oxobutyl acetate
(3s,3ar,4as,7s,7as,8s,9ar)-3,4a,8-trimethyl-2,5-dioxo-octahydro-3h-azuleno[6,5-b]furan-7-yl acetate
3,4a,8-trimethyl-2,5-dioxo-octahydro-3h-azuleno[6,5-b]furan-7-yl acetate
[(3ar,4as,5s,7as,8s,9ar)-5-hydroxy-8-methyl-3-methylidene-2-oxo-octahydro-3ah-azuleno[6,5-b]furan-4a-yl]methyl acetate
[(2s)-2-[2-(tert-butoxy)-5-methoxy-4-methylphenyl]oxiran-2-yl]methyl acetate
(3ar,4s,7ar)-5-[(2s)-5-hydroxypentan-2-yl]-6-methyl-3-methylidene-2-oxo-3a,4,7,7a-tetrahydro-1-benzofuran-4-yl acetate
10-methyl-5-pentyl-13-(prop-1-en-2-yl)-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(9),2(7),3,5,10,12-hexaen-3-ol
3-[(2r,12bs)-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-2-yl]-5h-furan-2-one
(3r,3as,4s,10s,11ar)-3,6,10-trimethyl-2,9-dioxo-3h,3ah,4h,5h,8h,10h,11h,11ah-cyclodeca[b]furan-4-yl acetate
(4s,5s,9as)-4-hydroxy-6,6,9a-trimethyl-3-oxo-1h,4h,5h,5ah,7h,8h,9h-naphtho[1,2-c]furan-5-yl acetate
(2s,3s,3'ar,6'r)-6'-hydroperoxy-3',3',6'-trimethyl-1',3'a,4',5'-tetrahydro-2h-spiro[furan-3,2'-inden]-2-yl acetate
(3ar,4as,5s,7as,8s,9ar)-4a-(hydroxymethyl)-8-methyl-3-methylidene-2-oxo-octahydro-3ah-azuleno[6,5-b]furan-5-yl acetate
(3s,3as,7r,9s,11as)-7-hydroxy-3,10-dimethyl-6-methylidene-2-oxo-3h,3ah,4h,5h,7h,8h,9h,11ah-cyclodeca[b]furan-9-yl acetate
10'-hydroxy-1',2',5'-trimethyl-8'-oxaspiro[oxirane-2,12'-tricyclo[7.2.1.0²,⁷]dodecan]-5'-en-11'-yl acetate
(4r,5s,5as,9as)-4-hydroxy-6,6,9a-trimethyl-1-oxo-3h,4h,5h,5ah,7h,8h,9h-naphtho[1,2-c]furan-5-yl acetate
1-acetoxy-6α-hydroxy-4αh-1,10-secoeudesma-5(10),11(13)-dien-12,8β-olide
{"Ingredient_id": "HBIN002239","Ingredient_name": "1-acetoxy-6\u03b1-hydroxy-4\u03b1h-1,10-secoeudesma-5(10),11(13)-dien-12,8\u03b2-olide","Alias": "NA","Ingredient_formula": "C17H24O5","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT14126","TCMID_id": "236","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
1β-acetoxy-7-drimen-11α-ol-12,11-lactone
{"Ingredient_id": "HBIN002381","Ingredient_name": "1\u03b2-acetoxy-7-drimen-11\u03b1-ol-12,11-lactone","Alias": "NA","Ingredient_formula": "C17H24O5","Ingredient_Smile": "CC(=O)OC1CCC(C2C1(C3C(OC(=O)C3=CC2)O)C)(C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "176","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
4-acetoxy-1β,5β-epoxy-10αh-xantha-11(13)-en-12,8β-olide
{"Ingredient_id": "HBIN010159","Ingredient_name": "4-acetoxy-1\u03b2,5\u03b2-epoxy-10\u03b1h-xantha-11(13)-en-12,8\u03b2-olide","Alias": "NA","Ingredient_formula": "C17H24O5","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "191","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
6-α-acetyl-4-o-oxobedfordiaicacid
{"Ingredient_id": "HBIN012196","Ingredient_name": "6-\u03b1-acetyl-4-o-oxobedfordiaicacid","Alias": "NA","Ingredient_formula": "C17H24O5","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "474","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
8α-acetoxy-1β-hydroxyeudesm-3-en-5α,6β,7α,11βh-12,6-olide
{"Ingredient_id": "HBIN013617","Ingredient_name": "8\u03b1-acetoxy-1\u03b2-hydroxyeudesm-3-en-5\u03b1,6\u03b2,7\u03b1,11\u03b2h-12,6-olide","Alias": "NA","Ingredient_formula": "C17H24O5","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "217","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
Bakkenolide-X
{"Ingredient_id": "HBIN017543","Ingredient_name": "Bakkenolide-X","Alias": "NA","Ingredient_formula": "C17H24O5","Ingredient_Smile": "CC1CCC(C2C1(CC3(C2O)C(=C)COC3=O)C)OC(=O)C","Ingredient_weight": "308.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "35683","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "10733601","DrugBank_id": "NA"}